Achieving Targeted Treatment Outcomes in IBD : Episode 1

Opinion

Video

June 10, 2024

Treat-to-target in Inflammatory Bowel Disease

Author(s):

Silvio Danese, MD, PhD ,Bruce Sands, MD

Medical experts in inflammatory bowel disease (IBD) define the concept of "treat-to-target" within the context of IBD and provide current recommendations on treatment targets for ulcerative colitis and Crohn's disease, the two main forms of IBD.

EP: 1.Treat-to-target in Inflammatory Bowel Disease

EP: 2.Recommended Targets When Treating Ulcerative Colitis/Crohn’s Disease in Clinic

EP: 3.Transmural Healing and Monitoring in Ulcerative Colitis and Crohn’s Disease

EP: 4.Implementing Treat to Target in the Long-term in Inflammatory Bowel Disease

EP: 5.Suboptimal Treatment of Inflammatory Bowel Disease in Clinical Practice

EP: 6.Unmet Needs and Starting Advanced Treatment in Inflammatory Bowel Disease

EP: 7.Considerations for Choosing Advanced Treatments and Setting Patient Expectations

EP: 8.Combination Therapy in Inflammatory Bowel Disease

EP: 9.Measuring Patient Satisfaction with Inflammatory Bowel Disease Treatments and Communication Regarding Treatment Changes

What does treat-to-target (t2t) mean in IBD?
1. Is t2t the starting point for disease modification?
What are the recommended treatment targets for IBD? How do they vary between UC and CD?

Related Videos

Gregory Mattingly, MD I St. Charles Psychiatric Associates

Duloxetine for Patients with COPD Suffering from Comorbid Depression

Enhancing Standards for Ethical Responsibilities within Clinical Research

Do Not Sell My Information

Terms & Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2025 MJH Life Sciences

All rights reserved.